|5Feb 12, 5:02 PM ET

Lee Sam 5

5 · Cocrystal Pharma, Inc. · Filed Feb 12, 2021

Insider Transaction Report

Form 5
Period: 2020-12-31
Lee Sam
President and Co-CEO
Transactions
  • Award

    Stock Options (Right to Buy)

    2020-11-24+50,00050,000 total
    Exercise: $1.30Exp: 2030-11-24Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.
  • [F2]The stock options vest as follows: 25,000 incentive stock options will vest on the one year anniversary of the grant date and the remaining 25,000 incentive stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on February 28, 2022, subject to continued employment on each applicable vesting date.

Documents

1 file
  • 5
    ownership.xmlPrimary